Reported Earlier, Medicenna Therapeutics Doses First Patient In Phase 2 Monotherapy Dose Expansion Portion Of The ABILITY Study Evaluating MDNA11 In Select Types Of Solid Tumors
Stocks in this Quantisnow insightHealth Care
Quantisnow market dataNASDAQ
MDNA
Medicenna Therapeutics Corp.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for MDNA
Full MDNA profile on Quantisnow Follow MDNA and get a push notification the moment its next story breaks.